The magnesium ion, Mg 21 , is essential for all life as a cofactor for ATP, polyphosphates such as DNA and RNA, and metabolic enzymes, but whether it plays a part in intracellular signalling (as Ca 21 does) is unknown. Here we identify mutations in the magnesium transporter gene, MAGT1, in a novel X-linked human immunodeficiency characterized by CD4 lymphopenia, severe chronic viral infections, and defective T-lymphocyte activation. We demonstrate that a rapid transient Mg 21 influx is induced by antigen receptor stimulation in normal T cells and by growth factor stimulation in non-lymphoid cells. MAGT1 deficiency abrogates the Mg 21 influx, leading to impaired responses to antigen receptor engagement, including defective activation of phospholipase Cc1 and a markedly impaired Ca 21 influx in T cells but not B cells. These observations reveal a role for Mg 21 as an intracellular second messenger coupling cell-surface receptor activation to intracellular effectors and identify MAGT1 as a possible target for novel therapeutics.
The magnesium ion, Mg 21 , is essential for all life as a cofactor for ATP, polyphosphates such as DNA and RNA, and metabolic enzymes, but whether it plays a part in intracellular signalling (as Ca 21 does) is unknown. Here we identify mutations in the magnesium transporter gene, MAGT1, in a novel X-linked human immunodeficiency characterized by CD4 lymphopenia, severe chronic viral infections, and defective T-lymphocyte activation. We demonstrate that a rapid transient Mg 21 influx is induced by antigen receptor stimulation in normal T cells and by growth factor stimulation in non-lymphoid cells. MAGT1 deficiency abrogates the Mg 21 influx, leading to impaired responses to antigen receptor engagement, including defective activation of phospholipase Cc1 and a markedly impaired Ca 21 influx in T cells but not B cells. These observations reveal a role for Mg 21 as an intracellular second messenger coupling cell-surface receptor activation to intracellular effectors and identify MAGT1 as a possible target for novel therapeutics.
Mg 21 is the most abundant divalent cation in mammalian cells and is an essential cofactor for ATP, nucleic acids, and numerous enzymes in animals and plants [1] [2] [3] . Whether it serves as a second messenger in intracellular signalling is controversial [4] [5] [6] [7] [8] . Ca 21 , another alkaline earth metal, is well-established as a second messenger; this is because the concentration of free intracellular Ca 21 , [Ca 21 ] i , is 0.1 mM and that of free extracellular Ca 21 , [Ca 21 ] e , is 1 mM, creating a steep gradient that favours voltage-and ligand-gated Ca 21 influx signals 9 . By contrast, [Mg 21 ] i is 10-30 mM and mostly complexed with ATP and other molecules. Only 1-5% (0.2-1 mM) is cytosolic free Mg 21 . However, this is 100-fold below its electrochemical equilibrium potential, which theoretically allows regulated Mg 21 influxes 6, 10 . Mg 21 has been found to enhance lymphocyte activation in suboptimal Ca 21 concentrations by phytohaemagglutinin (PHA) but not ionomycin [11] [12] [13] . As ionomycin bypasses proximal T-cell antigen receptor (TCR) signals, optimal T-cell activation could require a magnesium-generated process upstream of Ca 21 signalling. Probes sensitive to Mg 21 have revealed changes in [Mg 21 ] i in lymphocytes following lectin stimulation 14, 15 . Nevertheless, how extracellular Mg 21 promotes cellular activation signals is unknown.
The molecular elucidation of primary immunodeficiencies often yields novel insights into lymphocyte signal transduction [16] [17] [18] . TCR signalling is critical for T-lymphocyte selection during ontogeny and for peripheral responses against foreign pathogens 19, 20 . Mutations in the zeta-chain-associated protein kinase of 70 kDa (ZAP70) tyrosine kinase in severe combined immunodeficiency patients illustrated its role in thymic development of CD8 1 T cells and peripheral T-cell activation 19, 21 . Likewise, genetic defects in severe combined immunodeficiency patients in ORAI1 revealed that it was a critical storeoperated Ca 21 channel 22 . Idiopathic CD4 lymphocytopenia (ICL) is a rare immunodeficiency in which circulating CD4 1 T-cell counts are ,300 mm 23 or ,20% of total T cells in the absence of HIV infection or other causes of lymphopenia [23] [24] [25] . The aetiology of ICL is heterogeneous, with no infectious cause identified and a genetic aetiology suspected in some cases [26] [27] [28] [29] . Here we have uncovered a second messenger role for Mg 21 in receptor-induced phospholipase Cc1 (PLCc1) activation and Ca 21 signalling by discovering an X-linked mutation in MAGT1, a highly selective transporter for Mg 21 , in a subset of ICL patients.
Immune and gene defects in ICL patients
We examined two young brothers (patients A.1 and A.2) who exhibited recurrent infections, including chronic Epstein-Barr virus infection and low CD4 1 T-cell counts; other lymphocyte populations were normal or elevated, and immunoglobulin levels and vaccine responses were only intermittently defective (Supplementary Table 1 , Supplementary Fig. 1a, b ). Both patients had an inverted CD4:CD8 ratio and reduced CD31 1 cells in the naïve (CD27 1 , CD45RO 2 ) CD4 1 T-cell population, suggesting diminished thymic output [30] [31] [32] (Fig. 1a,  b ). However, we also found pronounced defects in TCR-mediated activation events, including CD69, CD25, Fas (CD95) and CTLA-4 upregulation following OKT3 (agonistic anti-CD3) stimulation in peripheral blood mononuclear cells (PBMCs) ( Fig. 1c , Supplementary Table 1 , Supplementary Fig. 2a ). Early TCR signalling events, such as NF-kB and NFAT nuclear translocation, were impaired ( Fig. 1e, f) . By contrast, the patients' T cells were fully activated by the downstream inducers phorbol 12-myristate 13-acetate (PMA) and ionomycin, implying a proximal TCR activation defect ( Fig. 1c , e, f). The patients showed no defect in B-cell receptor (BCR) or toll-like receptor (TLR) stimulation of B cells ( Fig. 1d, Supplementary Fig. 2b ).
Given that family A harboured two affected boys ( Fig. 2a ), we tested for X-chromosome linkage by assessing lyonization, the process of X-chromosome inactivation by methylation in females 33 . Skewed lyonization reflects the reduced fitness of cells due to a deleterious X-chromosome mutation. We digested genomic DNA with the methylation-sensitive restriction endonuclease HpaII to eliminate all active non-methylated X-chromosome DNA and analysed the remaining undigested (inactive) X chromosome by PCR at an indicator locus 33 . The mother of the two affected boys exhibited completely skewed lyonization with only the X chromosome inherited by her two sons inactivated in her T cells, strongly suggesting that she carries an X-linked genetic defect ( Fig. 2b) .
We therefore performed X-chromosome exon-capture and singleend next-generation sequencing on the mother and the two boys, yielding 18-20 million reads per subject with at least 103 coverage in ,90% of target regions. This revealed a 10-base-pair (bp) deletion in the two brothers present in MAGT1 ( Fig. 2c , Supplementary Fig. 3a ), a gene encoding a magnesium transporter [34] [35] [36] . This deletion was not detected in the mother's complementary DNA or 100 normal individuals (data not shown). The deletion removes a splice donor site located in the 39 exon-intron junction of exon 7 and was present in the grandmother and great-grandmother of the patients ( Fig. 2a , c, Supplementary Fig. 3a ). The patients' mutant MAGT1 splice variant was ,150 bp smaller than the mother's normal splice variant of approximately 1,100 bp and missing both exon 7 and 8, leading to a premature stop codon ( Supplementary Fig. 3b , c). Apparent nonsensemediated decay caused markedly decreased messenger RNA expression ( Fig. 2d ). The MAGT1 protein was undetectable in the patients' cells by western blot or immunofluorescent cell surface staining ( Fig. 2e , f).
Additional screening yielded another immunodeficient patient (B.1) with chronic Epstein-Barr virus infection and a nonsense mutation in exon 3 of MAGT1, leading to a 90% decrease in mRNA expression ( Fig. 2a , c, d, Supplementary Table 1 , Supplementary Fig. 4a ). The patient died five years ago from chronic Epstein-Barr virus-associated lymphoma at the age of 45. Like the other two patients, patient B.1 exhibited a similar T-cell defect in NF-kB and NFAT nuclear translocation in response to TCR but not PMA/ionomycin stimulation ( Supplementary Fig. 4b, c ).
TCR-induced Mg 21 and Ca 21 influx defects
MAGT1 is a mammalian Mg 21 -selective transporter whose physiological function is not well understood 34, 35 . The full-length protein of 367 amino acids encodes a signal peptide, a large amino-terminal segment, four transmembrane domains, and a small carboxyterminal tail with little similarity to any other known transporter except TUSC3, a non-selective Mg 21 transporter 36 . We measured ion uptake in normal and patients' lymphocytes using fluorescent probes sensitive for Ca 21 (Fluo3-AM and Fura red-AM) or Mg 21 (Magfluo4-AM), which exhibited no detectable cross-reactivity ( Supplementary Fig. 5a ). Initial experiments showed a low basal level 
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of free Mg 21 and defective passive Mg 21 influx, whereas that for Ca 21 was normal ( Supplementary Fig. 5a ). The total Ca 21 and Mg 21 levels in the patients' T cells determined by inductively coupled plasma mass spectrometry were normal, indicating that MAGT1 deficiency chiefly affects free Mg 21 and that general metabolic processes requiring bound Mg 21 should not be affected ( Supplementary Fig. 5b ). We next examined whether various TCR stimuli would affect free Mg 21 transport. We observed a robust transient Mg 21 influx together with the well-documented Ca 21 influx in normal PBMCs stimulated with various TCR agonists (Fig. 3a) . The apparent Mg 21 influx was not due to cross-detection of the Ca 21 influx, because the specific Ca 21 chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic acid acetoxymethyl ester (BAPTA-AM) abolished the Ca 21 fluorescence but not the Mg 21 fluorescence ( Supplementary Fig. 6a ). The Mg 21 influx was not detectable in the patients' T cells even with the strongest TCR agonist tested (5 mg ml 21 anti-CD3) (Fig. 3b, c) . Surprisingly, we also found that the Ca 21 influx was severely compromised in the patients' T cells across a broad dose range of anti-CD3 stimulation (Fig. 3b, c) . The TCR-induced Mg 21 influx was selective, as stimulation of T cells with secondary lymphoid tissue chemokine (SLC/CXCL21), Fas-ligand (FasL) and tumour necrosis factor-a (TNFa) caused no Mg 21 influx and the Ca 21 influxes induced by SLC and FasL were normal in the patient's cells ( Supplementary Fig.  6b ). Also, no Mg 21 influx was discernible in B lymphocytes following anti-IgM and anti-CD40 stimulation, and the ensuing Ca 21 influx was not diminished in patients' B cells ( Supplementary Fig. 6c ). Although the patients' B cells exhibited reduced basal free Mg 21 , their B-cell activation was normal (Fig. 1d) .
We next examined the hypothesis that the defective Ca 21 influx in the patients was secondary to the loss of the Mg 21 influx. We first explored the relationship between the TCR-stimulated influxes in normal T cells by modulating [Mg 21 ] and [Ca 21 ] in the extracellular buffer. Both Mg 21 and Ca 21 influxes were optimal when [Mg 21 ] e and [Ca 21 ] e 5 1 mM, respectively, but were abolished when [Mg 21 ] e and [Ca 21 ] e 5 0, respectively (Fig. 4a) . Moreover, when [Mg 21 ] e 5 0, the Ca 21 influx was decreased, but when [Ca 21 ] e 5 0, the Mg 21 influx was unaffected (Fig. 4a) . These results show that the TCR-induced Ca 21 influx is partially dependent on [Mg 21 ] e . Thus, we infer that the Ca 21 influx defect in T cells associated with MAGT1 deficiency is secondary to the loss of the TCR-stimulated Mg 21 influx. Conversely, when [Mg 21 ] e 5 0, the Ca 21 influx in B cells after the BCR stimulation is normal, which is consistent with the absence of BCR-induced Mg 21 influxes (Fig. 4b, Supplementary Fig. 6b ). Thus, the loss of the TCR-induced Ca 21 influx in the absence of extracellular Mg 21 is not likely to be due to a deficiency in Mg 21 as a cofactor required for ATPdependent processes, as B cells had no comparable defect. This is underscored by the fact that both B and T cells from the MAGT1deficient patients had the same partial reduction in the free [Mg 21 ] i , but only the latter exhibited functional defects in antigen receptor signalling.
To determine whether Mg 21 -promoted Ca 21 influxes are important in other tissues, we treated two transformed epithelial cell lines, A549 and HepG2, with epidermal growth factor (EGF), which is known to cause a PLCc1-dependent Ca 21 influx analogous to that induced by TCR engagement 37 . In each cell type, we observed a clear 
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dose-dependent influx of Mg 21 induced by EGF that was abrogated when [Mg 21 ] e 5 0 ( Fig. 4c, Supplementary Fig. 7) . The EGF-induced Ca 21 
Knockdown and reconstitution of MAGT1
To demonstrate that decreased MAGT1 expression can account for the immunological and signalling defects observed in the patients, we knocked down MAGT1 in normal human T cells by transient short interfering RNA (siRNA) transfections. We found that the TCRstimulated Mg 21 and Ca 21 influxes were decreased in proportion with the degree of MAGT1 mRNA knockdown (Fig. 5a , Supplementary Fig. 8a ). Similar to the patients' T-cell phenotype, MAGT1 knockdown impeded TCR-induced p65 nuclear translocation ( Fig. 5b, Supplementary Fig. 8b) . These results verify that MAGT1 is necessary for normal T-cell activation.
To determine whether MAGT1 deficiency is sufficient to explain the patients' functional defects, we reconstituted MAGT1 expression by lentiviral transduction of patient T cells. Positively transduced cells marked by a coexpressed fluorescent marker (mCherry) were examined by live cell confocal imaging of the influxes. We found that expressing wild-type MAGT1 in the patients' T cells restored a TCR-stimulated Mg 21 influx (Fig. 5c ). MAGT1 restoration also improved the TCRstimulated Ca 21 influx, thereby validating our conjecture that it is contingent on the Mg 21 influx (Fig. 5c ). The expression of MAGT1 also augmented other activation events of the patients' T cells, such as TCR-induced CD69 upregulation (Fig. 5d ). Thus, MAGT1 is necessary and sufficient for the Mg 21 influx required for optimal T-cell activation, and MAGT1 deficiency is the proximate cause of the T cell activation defect in this primary immunodeficiency.
Loss of MAGT1 impairs PLCc1 activation
To understand the molecular mechanism of the Ca 21 influx defect observed in MAGT1-deficient patients, we examined proximal TCR signalling components (Fig. 6d ). TCR engagement causes clustering and phosphorylation of the CD3f chain by the Src-family leukocytespecific protein tyrosine kinase (Lck) and subsequent recruitment of the protein tyrosine kinase ZAP70, which phosphorylates the scaffold proteins linker of activated T cells (LAT) and Src homology 2 (SH2) domain-containing leukocyte protein of 76 kDa (SLP76) 20, 38 . These phosphorylated scaffolds then bind inducible T cell kinase (Itk), which activates PLCc1 and thereby generates inositol triphosphate (IP 3 ) and diacylglycerol (DAG) as second messengers to trigger Ca 21 mobilization and protein kinase Ch (PKCh) activation, respectively. The Ca 21 influx modulates the protein phosphatase calcineurin, which, together with PKCh, activates downstream transcription factors such as NF-kB and NFAT 39 . We found that TCR cluster formation and LAT and PLCc1 recruitment to these clusters were intact in patient T cells after anti-CD3 stimulation (Fig. 6a , Supplementary  Fig. 9 ). Moreover, early TCR activation events including the phosphorylation of CD3f, Lck, ZAP70 and LAT induced by TCR ligation were normal in the patient's T cells using flow cytometric staining ( Supplementary Fig. 10 ) and western blots (Fig. 6b ). Again, this normal series of activation events excludes a general defect in Mg 21 as a co-factor for ATP-requiring processes accounting for the TCR signalling defects in MagT1-deficient T cells. By contrast, PLCc1 activation was markedly delayed by almost one hour in the patient T cells compared to healthy control T cells (Fig. 6b) . Moreover, the activating phosphorylation of PKCh and IP 3 generation downstream of PLCc1 were significantly reduced (Fig. 6b, c) . On the other hand, we found that TCR signalling events that do not require PLCc1, such as the phosphorylation of the mitogen activated protein kinases (MAPKs) p38 and Erk1/2, were intact in the patient T cells (Fig. 6b ). This deficiency in PLCc1 and PKCh activation following TCR stimulation was recapitulated by RNAi silencing of MAGT1 in normal T lymphocytes ( Supplementary Fig. 11 ). Thus, Mg 21 can regulate signal transduction pathways involving PLCc1 in lymphoid and non-lymphoid cells, and MAGT1-deficiency profoundly delays the activation of the PLCc1 branch of TCR signalling.
Discussion
We have found a biologically important transient Mg 21 influx mediated by MAGT1 during T-cell activation and EGF stimulation of epithelial cells. Three fundamental features of a second messenger have been put forward 40 : (1) its levels must increase rapidly in response to a stimulus, which is typically the engagement of a cell-surface receptor (first messenger), (2) it needs to alter the rate of one or more cellular processes, and (3) it exerts cell-type specific activity because different cells harbour different complements of enzymes. We find that Mg 21 fulfils these requirements and is a kinetic regulator of signalling in T cells. We found no difference in total Mg 21 content between our patients and healthy controls, indicating that MAGT1 does not influence general Mg 21 homeostasis or its cofactor function. Rather, we measured rapid and transient free Mg 21 influxes after TCR engagement which depends on the MAGT1 transporter. These transient Mg 21 influxes increased the rate of PLCc1 activation and the corresponding Ca 21 
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mitogens, and that mice fed Mg 21 -deficient diets have lower calcineurin activity in their splenocytes [11] [12] [13] 41, 42 . It will also be of interest to determine if defective thymopoiesis caused by disruption of the TRPM7 Mg 21 channel could be due to the loss of the signalling function of Mg 21 influxes 43 .
The patients examined in this study have a novel X-linked primary immunodeficiency impairing thymic production of CD4 1 T cells and circulating T-cell function which we now denominate XMEN (X-link immunodeficiency with magnesium defect and Epstein-Barr virus infection and neoplasia) disease. The defective development and function of T cells in XMEN patients categorizes them as T cell immunodeficiency patients, although they have a mild phenotype comprising chiefly uncontrolled viral infections consistent with a T-cell-specific defect 44 . They also share features with X-linked lymphoproliferative disease (XLP) except for the absence of NKT cell deficits or haemophagocytic lymphohistiocytosis 45 . Like XMEN patients, mice with PLCc1-deficient T cells have fewer CD4 1 T cells and defective TCR activation, but they also have features that we did not observe in the patients, such as impaired ERK activation, lower numbers of CD8 1 T cells and FoxP3 1 regulatory T cells, and inflammatory/autoimmune symptoms 46 . The fact that XMEN patients only have a kinetic block in PLCc1 activation, whereas the mice have a complete deficiency, could account for these differences.
Finally, the integrity of early TCR activation events in the patients' T cells explains how MAGT1 acts as a TCR-gated transporter that controls a new step in the later contingent series of TCR signalling events 47 (Fig. 6d) . The selective requirement of this Mg 21 influx for the activation of T cells but not B cells suggests that MAGT1 may be a useful therapeutic target for diseases requiring T-cell-specific immunomodulation.
METHODS SUMMARY
All human subjects in this study provided informed consent in accordance with Helsinki principles to be enrolled in research protocols approved by the institutional review board of the National Institute of Allergy and Infectious Diseases, NIH. Patients' and healthy control PBMCs were Ficoll-purified and activated with anti-CD3 and anti-CD28 for 3 days and then continuously cultured in 10% RPMI media supplemented with 100 U ml 21 IL-2 for 3-4 weeks. For assessment of primary stimulation, cells were collected and stained with anti-CD2, anti-CD4 and anti-CD8 antibodies, and various activation markers for 30 min at 4 uC and analysed with a FACS Calibur or a LSRII flow cytometer (BD Biosciences). Activated T cells were restimulated with various T-cell activation agents, and processed for immunofluorescence imaging, immunoblotting and influx assays, as described in Methods. Genomic DNA isolated from activated T cells was prepared for lyonization assays, SureSelect Human X Chromosome (Agilent) target enrichment, single-read Solexa sequencing on Illumina Genome Analyser IIx, and Sanger sequencing according to the manufacturer's instructions. All P values were calculated with the Student's t-test using PRISM software (GraphPad Software), with a two-tailed distribution.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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